In this study, researchers want to test a new blood test that they have developed which can tell doctors if a person is responding to the drug bevacizumab. Bevacizumab is a type of targeted therapy that works by blocking a growth factor (like a hormone) that makes blood vessels. This growth factor is called VEGF. By blocking VEGF, some cancers i…

The study aims to find out the answers to the following questions: Is one of these treatment approaches better than the other? Which treatment causes fewer side effects? Which treatment offers a better quality of life? Is it safe to use bevacizumab to treat women who are having surgery at the same time as chemotherapy? If you take …